It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATAI’s FA Score shows that 1 FA rating(s) are green whileTAL’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATAI’s TA Score shows that 3 TA indicator(s) are bullish while TAL’s TA Score has 4 bullish TA indicator(s).
ATAI (@Biotechnology) experienced а -10.88% price change this week, while TAL (@Miscellaneous Commercial Services) price change was -8.08% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.
The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was -2.59%. For the same industry, the average monthly price growth was -5.04%, and the average quarterly price growth was +5.21%.
ATAI is expected to report earnings on May 20, 2025.
TAL is expected to report earnings on Jul 24, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Miscellaneous Commercial Services (-2.59% weekly)The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.
ATAI | TAL | ATAI / TAL | |
Capitalization | 260M | 7.25B | 4% |
EBITDA | -124.33M | -121.57M | 102% |
Gain YTD | -1.504 | 22.555 | -7% |
P/E Ratio | N/A | N/A | - |
Revenue | 331K | 1.33B | 0% |
Total Cash | 85.9M | 3.17B | 3% |
Total Debt | 23.8M | 214M | 11% |
ATAI | TAL | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 67 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 80 Overvalued | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 95 | 86 | |
PRICE GROWTH RATING 1..100 | 64 | 46 | |
P/E GROWTH RATING 1..100 | 11 | 83 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ATAI's Valuation (80) in the Miscellaneous Commercial Services industry is in the same range as TAL (84) in the Other Consumer Services industry. This means that ATAI’s stock grew similarly to TAL’s over the last 12 months.
ATAI's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as TAL (100) in the Other Consumer Services industry. This means that ATAI’s stock grew similarly to TAL’s over the last 12 months.
TAL's SMR Rating (86) in the Other Consumer Services industry is in the same range as ATAI (95) in the Miscellaneous Commercial Services industry. This means that TAL’s stock grew similarly to ATAI’s over the last 12 months.
TAL's Price Growth Rating (46) in the Other Consumer Services industry is in the same range as ATAI (64) in the Miscellaneous Commercial Services industry. This means that TAL’s stock grew similarly to ATAI’s over the last 12 months.
ATAI's P/E Growth Rating (11) in the Miscellaneous Commercial Services industry is significantly better than the same rating for TAL (83) in the Other Consumer Services industry. This means that ATAI’s stock grew significantly faster than TAL’s over the last 12 months.
ATAI | TAL | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago80% | 2 days ago79% |
Momentum ODDS (%) | 2 days ago84% | 2 days ago81% |
MACD ODDS (%) | 2 days ago81% | 2 days ago74% |
TrendWeek ODDS (%) | 2 days ago84% | 2 days ago80% |
TrendMonth ODDS (%) | 2 days ago83% | 2 days ago83% |
Advances ODDS (%) | 13 days ago80% | 10 days ago83% |
Declines ODDS (%) | 2 days ago85% | 2 days ago82% |
BollingerBands ODDS (%) | 2 days ago88% | 2 days ago90% |
Aroon ODDS (%) | 2 days ago87% | 4 days ago80% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TFJL | 21.20 | 0.22 | +1.05% |
Innovator 20 Year Treasury Bond 5 Floor ETF | |||
MQT | 9.90 | -0.17 | -1.69% |
Blackrock Muni Yield Quality Fund II | |||
FID | 16.56 | -0.82 | -4.72% |
First Trust S&P Int Div Aristocrats ETF | |||
ONEQ | 61.42 | -3.74 | -5.73% |
Fidelity Nasdaq Composite ETF | |||
SDIV | 19.04 | -1.26 | -6.21% |
Global X SuperDividend™ ETF |
A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.
Ticker / NAME | Correlation To ATAI | 1D Price Change % | ||
---|---|---|---|---|
ATAI | 100% | -0.38% | ||
MNMD - ATAI | 48% Loosely correlated | -2.16% | ||
CYBN - ATAI | 46% Loosely correlated | -4.53% | ||
COUR - ATAI | 45% Loosely correlated | -1.26% | ||
VCYT - ATAI | 45% Loosely correlated | +1.69% | ||
RXRX - ATAI | 44% Loosely correlated | -11.85% | ||
More |
A.I.dvisor indicates that over the last year, TAL has been loosely correlated with GOTU. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if TAL jumps, then GOTU could also see price increases.
Ticker / NAME | Correlation To TAL | 1D Price Change % | ||
---|---|---|---|---|
TAL | 100% | -9.10% | ||
GOTU - TAL | 60% Loosely correlated | -2.34% | ||
EDU - TAL | 58% Loosely correlated | -6.63% | ||
ATAI - TAL | 27% Poorly correlated | -0.38% | ||
TCTM - TAL | 24% Poorly correlated | +14.14% | ||
BCO - TAL | 23% Poorly correlated | -2.05% | ||
More |